A new front in the war against the war on drugs has opened up. It has been less than two years since voters in Denver decriminalized the possession of magic mushrooms, but since then, a number of cities have moved in a similar direction. More dramatically, in last November's elections, Oregon voted to allow the therapeutic use of psilocybin, the primary active ingredient in those mushrooms (as well as voting to decriminalize the possession of all drugs) and Washington, DC, voted to effectively decriminalize "natural entheogens" by making them the lowest law enforcement priority.

[image:1 align:left caption:true]This year, psychedelic reform is making its way to statehouses around the country -- and it has already scored its first victory in New Jersey (see below). Spurred by the potential of psychedelics in treating mental health disorders as well as by the dawning recognition that these drugs are just not that dangerous, and just possibly the racial and class composition of psychedelic aficionados, the movement to end the war on psychedelics is buzzing like never before.

The movement is not without controversy even among drug reformers, with some decrying "psychedelic exceptionalism" and demanding the decriminalization of all drugs, and others wondering why natural psychedelics like psilocybin should be treated differently from synthetic ones like LSD, but those debates are for another article. Here, we simply marvel at the rapid movement on the psychedelic front as we review what is popping up in the state legislatures.

And here is what is going on (with a big tip of the hat to Marijuana Moment, which provides a list of marijuana, psychedelic, and other drug reform bills to its paying subscribers):

California -- Psychedelic Decriminalization

Sen. Scott Weiner (D-San Francisco) and three cosponsors have filed Senate Bill 519, which would make it legal for persons 21 and over to possess and share psilocybin and psilocyin, DMT, ibogaine, mescaline, LSD, ketamine, and MDMA. The bill would also mandate that the Department of Public Health create a working group to make recommendations to the legislature on the regulation and therapeutic use of these substances. The bill has been referred to the Public Safety and Health committees and is set for a hearing on April 6.

Connecticut -- Psilocybin Health Benefits Study

Rep. Josh Elliott (D-Hamden) and five cosponsors have filed HB 06296, which would create a task force to study the health benefits of psilocybin. The measure has been before the Joint Committee on Public Health since January 29.

Florida -- Therapeutic Psilocbyin

Reps. Mike Grieco (D-Miami-Dade) and Nick Duran (D-Miami-Dade) have filed HO549, which would create a path for the use of psilocybin as a mental health treatment by establishing a Psilocybin Advisory Board and ordering the Health Department to adopt rules and regulations and exceptions for the therapeutic administration of psilocybin. The bill would also make psilocybin possession offenses the lowest law enforcement priority. It is now in the Professions and Public Health Services Subcommittee of the Health and Human Services Committee, and has also been referred to two more subcommittees.

Iowa -- Therapeutic Psilocybin

Rep. Jeff Shipley (R-Birmingham) has filed House File 636, which would create the Psilocybin Services Act with the Department of Public Health in charge of developing rules and regulations allowing for the therapeutic administration of psilocybin. The bill envisions licensed psilocybin service centers, psilocybin service facilitators, and psilocybin testing laboratories. It is currently before the Senate Public Safety Committee. The bill is a fallback for Shipley, whose earlier House File 459, which would have simply decriminalized psilocybin and psilocyin, has already been killed in subcommittee.

New Jersey -- Reducing Psilocybin Penalties

Senator Nick Scutari (D-Linden) filed S3256, which lessens the penalty for the possession of any amount of psilocybin from a third degree misdemeanor to a disorderly persons offense punishable by up to six months in jail and/or a $1,000 fine. The bill passed both the Assembly and the Senate and was signed into law by Gov. Phil Murphy (D) in February.

New York -- Psilocybin Decriminalization

Rep. Linda Rosenthal (D-Manhattan) has filed AO6065, which would decriminalize psilocybin and psilocin by deleting them from the state's register of controlled substances. The bill was referred to the Assembly Health Committee on March 8.

Texas -- Therapeutic Study

State Rep. Steve Dominguez (D-Brownsville) has filed House Bill 1802, which calls for a study by the Health Department and the Texas Medical Board of the therapeutic efficacy of alternative therapies including MDMA, psilocybin, and ketamine for the treatment of mental health and other medical conditions, including chronic pain and migraines. The bill was referred to the House Public Health Committee on March 11.

Vermont -- Natural Psychedelic Decriminalization

Rep. Brian Cina (D) and nine cosponsors have filed H0309, which would decriminalize the possession of ayahuasca, DMT, ibogaine, peyote, and psilocybin and psilocin and "any plants or fungi containing the substances" by removing them from the state's schedule of regulated drugs. The bill has been in the Committee on the Judiciary since February.

We will have to check back on this once the legislators have gone home.